BVS: the balance sheet

MyFinsight

For the quarter ending 2025-09-27, BVS has $701,593K in assets. $494,338K in debts. $42,164K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-27	2025-06-28
Cash and cash equivalents	42,164	32,910
Accounts receivable, net	130,404	132,367
Inventory	96,273	96,465
Prepaid and other current assets	12,060	13,461
Total current assets	280,901	275,203
Property and equipment, net	22,983	24,512
Goodwill	7,462	7,462
Intangible assets, net	377,398	386,954
Operating lease assets	5,830	6,225
Deferred tax assets	4,745	4,745
Investment and other assets	2,274	1,687
Total assets	701,593	706,788

Accounts payable	26,649	24,245
Accrued liabilities	119,446	113,666
Current portion of long-term debt	11,250	43,358
Current portion of contingent consideration	0	0
Other current liabilities	4,407	4,411
Total current liabilities	161,752	185,680
Long-term debt, less current portion	311,334	297,880
Deferred income tax liabilities	786	651
Other long-term liabilities	20,466	21,278
Total liabilities	494,338	505,489
Common stock, value-Common Class A	67	67
Common stock, value-Common Class B	16	16
Additional paid-in capital	517,534	514,772
Accumulated deficit	-349,684	-352,839
Accumulated other comprehensive loss	-1,837	-774
Total stockholders equity attributable to bioventus inc	166,096	161,242
Noncontrolling interest	41,159	40,057
Total stockholders equity	207,255	201,299
Total liabilities and stockholders equity	701,593	706,788

Unit: Thousand (K) dollars